South Dakota Statutes

§ 58-29G-2 — General protections--Exclusions.

South Dakota·Title 58 INSURANCE·Ch. 58-29F PHARMACY AUDIT INTEGRITY PROGRAM
A pharmaceutical manufacturer may not, directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug or the delivery of a 340B drug to a location that is authorized to receive the drug by a 340B entity or pharmacy, unless receipt of the 340B drug is prohibited by federal law. Nothing in this section requires a pharmaceutical manufacturer to provide a 340B drug price discount to a pharmacy. Nothing in this section prohibits a pharmaceutical manufacturer from limiting distribution of a drug in accordance with 21 U.S.C. § 3 55-1 (January 1, 2025).

Free access — add to your briefcase to read the full text and ask questions with AI

South Dakota § 58-29G-2 (General protections--Exclusions.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 3
21 U.S.C. § 3

Legislative History

SL 2025, ch 198, § 3.

Nearby Sections

15
View on official source ↗